BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31061338)

  • 1. [Study of the Metabolism of New Drugs of Abuse].
    Kanamori T
    Yakugaku Zasshi; 2019; 139(5):699-704. PubMed ID: 31061338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl.
    Kanamori T; Togawa-Iwata Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Inoue H
    Forensic Toxicol; 2018; 36(2):467-475. PubMed ID: 29963210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of Fentanyl and Acetylfentanyl in Human-Induced Pluripotent Stem Cell-Derived Hepatocytes.
    Kanamori T; Togawa Iwata Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Inoue H
    Biol Pharm Bull; 2018; 41(1):106-114. PubMed ID: 29311471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450-dependent drug oxidation activities in commercially available hepatocytes derived from human induced pluripotent stem cells cultured for 3 weeks.
    Murayama N; Yamazaki H
    J Toxicol Sci; 2018; 43(4):241-245. PubMed ID: 29618712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
    Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.
    Kanamori T; Kanda K; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    Drug Test Anal; 2015 Apr; 7(4):341-5. PubMed ID: 25600155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of Butyrylfentanyl in Fresh Human Hepatocytes: Chemical Synthesis of Authentic Metabolite Standards for Definitive Identification.
    Kanamori T; Iwata YT; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Inoue H
    Biol Pharm Bull; 2019; 42(4):623-630. PubMed ID: 30930421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
    Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
    Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Plomer G; Seppen J; Ackermans MT; Camus S; Kulik W; van Gulik TM; Elferink RP; Chamuleau RA
    Drug Metab Dispos; 2013 Mar; 41(3):562-7. PubMed ID: 23238784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues.
    Hart SN; Li Y; Nakamoto K; Subileau EA; Steen D; Zhong XB
    Drug Metab Dispos; 2010 Jun; 38(6):988-94. PubMed ID: 20228232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
    Takayama K; Morisaki Y; Kuno S; Nagamoto Y; Harada K; Furukawa N; Ohtaka M; Nishimura K; Imagawa K; Sakurai F; Tachibana M; Sumazaki R; Noguchi E; Nakanishi M; Hirata K; Kawabata K; Mizuguchi H
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16772-7. PubMed ID: 25385620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urine.
    Richter LHJ; Maurer HH; Meyer MR
    Toxicol Lett; 2017 Oct; 280():142-150. PubMed ID: 28782580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes.
    Sjogren AK; Liljevald M; Glinghammar B; Sagemark J; Li XQ; Jonebring A; Cotgreave I; Brolén G; Andersson TB
    Arch Toxicol; 2014 Jul; 88(7):1427-37. PubMed ID: 24912781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.